Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries Limited (TEVA) Stock Overview

Explore Teva Pharmaceutical Industries Limited’s financial performance, market position, analyst ratings, and future outlook.

TEVA●NYSE
HealthcareDrug Manufacturers - Specialty & Generic
$37.10
$0.62(1.70%)
U.S. Market is Open · 13:57

Teva Pharmaceutical Industries Limited (TEVA)

Meyka AI Score

Z

Key Financials

Market Cap42.8B
P/E Ratio58.44
EPS (TTM)$2.93
ROE0.09%
Fundamental Analysis

AI Price Forecasts

1 Month$32.81
3 Months$38.13
1 Year Target$41.96

TEVA Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Teva Pharmaceutical Industries Limited (NYSE: TEVA) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Teva Pharmaceutical Industries Limited's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of TEVA on the NYSE shows an RSI of 67.81, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $41.96 for the NYSE listing.

Key metrics behind Teva Pharmaceutical Industries Limited's NYSE-traded stock include a P/E ratio of 58.44 and a market capitalization of 42.8B. Combined with our AI analysis, these give both institutional and retail investors a clear view of TEVA on the NYSE.

Price Performance (NYSE: TEVA)

1-Day Change
0.71%
5-Day Change
4.97%
1-Month Change
11.50%
3-Month Change
2.60%
6-Month Change
8.31%
Year-to-Date (YTD) Change
17.72%
1-Year Change
121.33%
3-Year Change
284.71%
5-Year Change
267.77%
All-Time (Max) Change
3954.07%

Contact Information

https://www.tevapharm.com
972 3 914 8213
124 Dvora Hanevi'a Street, Tel Aviv, TA, 6944020

Company Facts

320,080 Employees
IPO DateFeb 16, 1982
CountryIL
Actively Trading

Frequently Asked Questions